Preparedness to Combat Infectious Disease and Drug-Resistant Bacterial Threats

New Publication!

View the one-page 'takeaways' publication under the Materials section at the top of this webpage.

Webinar for Policymakers

For part two of our three-part webinar series, Duke-Margolis invites policymakers, legislative advisors, and others interested in addressing emerging infectious diseases to learn about emergency preparedness in the context of bacterial threats, like antimicrobial resistance (AMR). Expert speakers will highlight: 

• Key similarities and differences between viral and bacterial threats, including their respective impact on national security, global public health, and economic prosperity;

• Antiviral and antibacterial product supply chains and manufacturing, and the potential impact of future health emergencies or global infectious disease outbreaks; and
• Incentives for antibiotic manufacturing and supply chain resilience, bacterial threat surveillance, evidence development infrastructure, and diagnostic innovation that can bolster public health preparedness and mitigate the threat of antibiotic resistant infections.

Expected Outcome

Discussion will inform policy approaches that decision-makers can pursue to advance emergency preparedness, particularly approaches that align actions to address both viral and bacterial threats, and approaches that support access to current and future life-saving antibiotics.

Funding Acknowledgement & Disclosure

The AMR Action Fund provided funding for this Duke-Margolis webinar. However, the views and conclusions shared by webinar speakers are solely those of the speakers and do not reflect the official position nor endorsement of the AMR Action Fund or any organization associated with the speakers.